Get my own profile
Public access
View all9 articles
0 articles
available
not available
Based on funding mandates
Co-authors
Philippe BeutelsProfessor at Vaccine & Infectious Disease Institute, University of Antwerp, BelgiumVerified email at uantwerpen.be
Lander WillemUniversity of AntwerpVerified email at uantwerpen.be
Niel HensProfessor of BiostatisticsVerified email at uhasselt.be
Frederik VerelstAssociate Director, Vaccines Value Evidence / Health Outcomes, GlaxoSmithKlineVerified email at gsk.com
Jan BroeckhoveProfessor em., Dept. of Computer Science, Universiteit AntwerpenVerified email at uantwerpen.be
Joke BilckeCenter for Health Economics Research and Modeling of Infectious Diseases, University of AntwerpVerified email at uantwerp.be
Virginia E. PitzerYale School of Public HealthVerified email at yale.edu
Professor Sir Andrew PollardUniversity of OxfordVerified email at paediatrics.ox.ac.uk
A. David PaltielYale UniversityVerified email at yale.edu
Marina AntillonSwiss Tropical and Public Health InstituteVerified email at aya.yale.edu
Sean StijvenUniversity of AntwerpVerified email at ua.ac.be
Wim DelvaSACEMA and Dept of Global Health (Stellenbosch Univ) and ICRH (Ghent Univ)Verified email at sun.ac.za
Diana M HendrickxMicrobiology, Wageningen UR, The NetherlandsVerified email at wur.nl
David NiyukuriStellenbosch University/Faculty of Medicine and Health SciencesVerified email at sun.ac.za
Gerrit BeemsterProfessor of Plant Biology, University of AntwerpVerified email at uantwerpen.be
Follow
